Germ factories or immune boot camps? Infection and immunity in childcare settings
Clinical Microbiology Reviews · 11.06.2026 · 39 (2)
DOI: 10.1128/cmr.00253-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.06.2026. Verfasst von Sarah L Caddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Baker Institute for Animal Health, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Child Care, Communicable Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, UK Research and Innovation, University of Cambridge.
Abstract (Originalsprache)
Childcare outside the home is a common experience for many children in high-income countries. It is associated with an increase in the incidence of infectious diseases—not just for the child but also for their parents and other household members. In this review, we explore this phenomenon from multiple angles, combining age at first infection, maternal antibody dynamics, seroepidemiology, cohort studies, and outbreak reports to understand the relationship between the immune systems of children starting childcare and the pathogen milieu they encounter. We consider the interaction between the age at which many infants begin out-of-home childcare and the maturation of cellular and humoral immunity. We bring together data on what is “normal” for infections in the first years of life: the range and incidence of gastrointestinal, respiratory, and rash-forming illnesses that typically infect young children. We review evidence of the additional impact that childcare has on the transmission of these pathogens. The economic and personal impacts of these illnesses are considered, including our lived experiences. We ask whether there are effective interventions to reduce illness associated with childcare, as the UK adds chickenpox to the childhood vaccination schedule. Finally, we consider evidence suggesting a trade-off between infections earlier in life and when children start formal schooling. We conclude that the high burden of infection in young children is normal, linked to the immunobiology of infants and the transmission dynamics of individual pathogens, but the collective impact of these infections is underappreciated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Baker Institute for Animal Health, Cornell University, Ithaca, New York, USA.
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- UCL Genetics Institute, Department of Genetics, Evolution, and Environment, University College London, London, United Kingdom.
- Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, United Kingdom.
- North Middlesex University Hospital, Royal Free NHS Foundation Trust, London, United Kingdom.
- Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Sarah L Caddy, Lucy van Dorp, Leo Swadling, Charlotte J Houldcroft
Förderung
- Wellcome Trust
- UK Research and Innovation
- University of Cambridge
Zitieren
APA
Caddy, S. L., van Dorp, L., Swadling, L., Wang-Koh, Y. W., & Houldcroft, C. J. (2026). Germ factories or immune boot camps? Infection and immunity in childcare settings. Clinical Microbiology Reviews, 39(2). https://doi.org/10.1128/cmr.00253-25
Vancouver
Caddy SL, van Dorp L, Swadling L, Wang-Koh YW, Houldcroft CJ. Germ factories or immune boot camps? Infection and immunity in childcare settings. Clinical Microbiology Reviews. 2026;39(2). doi:10.1128/cmr.00253-25
BibTeX
@article{Caddy2026,
author = {Caddy, Sarah L and van Dorp, Lucy and Swadling, Leo and Wang-Koh, Yuan Wis and Houldcroft, Charlotte J},
title = {Germ factories or immune boot camps? Infection and immunity in childcare settings},
journal = {Clinical Microbiology Reviews},
year = {2026},
volume = {39},
number = {2},
doi = {10.1128/cmr.00253-25}
}
EUVIMED